Invesco Ltd. · IVZ · FY2026 Q2 · Calendar Q3 2026

Invesco: Record inflows support higher margins and product expansion

The supplied Q2 analysis supports a constructive operating thesis for Invesco: record inflows, ETF demand, product launches, partnerships, and operating leverage are reinforcing growth. That thesis remains conditional on sustaining flows and margins while managing fee compression and hybrid-platform execution.

Reported Before market openNYSEFinancial Services $13.63B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.71 Consensus $0.67
EPS surprise +6.6% Reported versus consensus
Reported revenue $1.33B Consensus $1.32B
Revenue surprise +0.8% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move -2.3% Event window
SPY move +0.2% Same window
Abnormal move -2.5% Stock minus SPY
Volume 1.8× Versus trailing sessions
Subsequent drift +11.2% Up to 20 sessions
IVZSPY benchmark

Ask FN2 about IVZ FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior-quarter analysis, the supplied Q2 analysis describes stronger inflows, a higher operating margin, continued QQQ international expansion, more than 50 new products launched during the year, and new tokenized-Treasury and Canadian sub-advisory developments. The focus also shifted toward sustaining high-30s margins while completing the hybrid-platform rollout.

Guidance delta

Management guidance sentiment was maintained; the supplied analysis highlights a sustained high-30s operating-margin target and continued platform and product expansion.

Key takeaways

  • Record net long-term inflows and higher assets under management indicate broad demand across regions and products.
  • ETF demand, particularly in the QQQ franchise, remained the central growth engine in the supplied analysis.
  • Operating-margin expansion and balance-sheet deleveraging strengthen the operating backdrop.
  • New products and partnerships broaden exposure to active ETFs, tokenized Treasuries, private markets, and international distribution.
  • The main offsets are fee compression, flow volatility, platform implementation costs, and private-market risk.

Management priorities

  • Expand the QQQ franchise internationally and through product extensions.
  • Launch additional active ETFs and continue the BulletShares rollout.
  • Complete the hybrid investment platform implementation and pursue related cost efficiencies.
  • Deepen partnerships and sub-advisory relationships across private markets and international channels.
  • Maintain capital returns through buybacks and dividends.

Follow IVZ with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
IVZ REVENUE earnings history estimate and actual scatter chart 9 reported fiscal quarters and 3 future estimate-only quarters. Q4 '23 estimate $1B Q4 '23 actual $1B, beat Q1 '24 estimate $1B Q1 '24 actual $1B, beat Q2 '24 estimate $1B Q2 '24 actual $1B, beat Q3 '24 estimate $1B Q3 '24 actual $2B, beat Q2 '25 estimate $1B Q2 '25 actual $1B, beat Q3 '25 estimate $1B Q3 '25 actual $1B, beat Q4 '25 estimate $1B Q4 '25 actual $1B, beat Q1 '26 estimate $1B Q1 '26 actual $1B, miss Q2 '26 estimate $1B Q2 '26 actual $1B, beat Q3 '26 estimate $1B Q4 '26 estimate $1B Q1 '27 estimate $1B
Show less

Analyst Consensus ?

ConsensusHold28 ratings
Bullish1242.9%
Neutral1657.1%
Bearish00.0%

Analyst 52W Price Targets

$30.74Current
$17Low
$28.67Average
$39High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 24, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Evercore ISI Group In Line In LineMaintainSep 9, 2026
TD Cowen Buy BuyMaintainAug 13, 2026
RBC Capital Outperform OutperformMaintainJul 29, 2026
JP Morgan Neutral NeutralMaintainJul 29, 2026
Barclays Equal Weight Equal WeightMaintainJul 29, 2026
Show 23 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $30.74. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
RBC CapitalAnalyst unavailable$39$32.02 +26.9%Aug 13, 2026
Evercore ISIAnalyst unavailable$35$32.05 +13.9%Aug 10, 2026
BarclaysAnalyst unavailable$32$29.43 +4.1%Jul 29, 2026
BarclaysAnalyst unavailable$31$28.4 +0.8%Jul 14, 2026
Evercore ISIAnalyst unavailable$32$29.08 +4.1%Jul 10, 2026
See 39 more

Track every rating change on IVZ the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Invesco Ltd. engages in the investment management business. Its products include mutual funds, unit trusts, exchange-traded funds, closed-end funds, and retirement plans. The company was founded in December 1935 and is headquartered in Atlanta, GA.

Historical context

All IVZ earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the IVZ recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-07-28T15:03:54.450010+00:00
  2. FN2 earnings calendar · 2026-09-02T01:23:14.593608+00:00
  3. Polygon adjusted daily market bars · 2026-09-24T03:20:56.090675+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-24T03:20:56.087459+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-24. For educational purposes only; not investment advice.